Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 224.80
+6.01 (2.75%)
Mar 28, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 297.96 billion as of March 31, 2025. Its market cap has increased by 80.76% in one year.
Market Cap
297.96B
Enterprise Value
341.74B
Revenue
89.49B
Ranking
n/a
PE Ratio
765.97
Stock Price
224.80
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 297.96B, an increase of 31.42%. That is a compound annual growth rate of 11.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 297.96B | -15.59% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.13B |
| Divi's Laboratories | 1,533.20B |
| Cipla | 1,164.75B |
| Mankind Pharma | 1,000.40B |
| Apollo Hospitals Enterprise | 951.31B |
| Zydus Lifesciences | 891.93B |
| Aurobindo Pharma | 674.02B |
| Alkem Laboratories | 583.68B |